Tc-TRODAT-1, as a tropane-derived compound with highly selective binding to the dopamine transporter, has been extensively used as an in vivo biomarker to evaluate parkinsonism. There have been few reports indicating various etiologies about extrastriatal findings on the Tc-TRODAT-1 SPECT. We herein present an interesting case about the incidental discovery of brain lymphoma with increasing uptake of Tc-TRODAT-1.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/RLU.0000000000002605 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!